Publications by authors named "Sandro Matosevic"

Claim this Profile
T
The differential regulation of the urea cycle in tumors goes awry.
Ahmed M Abou-Shanab, Mennatallah A Khedr, Sandro Matosevic

Biochem Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology, immunosuppression and NK cell immunotherapy of non-small cell lung cancer.
Xinyu Wu, Sandro Matosevic

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and Flow Cytometric Analysis of Natural Killer Cells from Human Glioblastoma Multiforme (GBM) Tissues.
Soumyajit Das, Kyle B Lupo, Veronika Slivova, Aaron A Cohen-Gadol, Sandro Matosevic

Curr Protoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance.
Zachary David Myers, Sandro Matosevic

Cancer Gene Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afamitresgene autoleucel: first cell therapy for synovial sarcoma.
Soumyajit Das, Sandro Matosevic

Trends Pharmacol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations.
Pawel Kalinski, Kathleen M Kokolus, Indu Ahluwalia, Mihaela Balu, Łukasz Balwicki, Sandro Matosevic

Wiad Lek· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diversity of natural killer cell functional and phenotypic states in cancer.
Kumar Rishabh, Sandro Matosevic

Cancer Metastasis Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and evaluation of cancer binding capacity of HLA-A2-WT1 complex-targeting antibody.
Xue Yao, Sandro Matosevic

Immunol Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy.
Kyle B Lupo, Xue Yao, Shambhavi Borde, Jiao Wang, Sandra Torregrosa-Allen, Sandro Matosevic

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses.
Soumyajit Das, Emmett Niemeyer, Zach A Leung, Tyler Fritsch, Sandro Matosevic

Mol Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
Pawel Kalinski, Kathleen M Kokolus, Rami Azrak, Mikhail Y Berezin, Renier Brentjens, Sandro Matosevic

Wiad Lek· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma.
Kyle B Lupo, Sandra Torregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia A Lanman, Sandro Matosevic

iScience· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities.
Shambhavi Borde, Sandro Matosevic

Trends Pharmacol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional expression of CD73 on human natural killer cells.
Andrea M Chambers, Jiao Wang, Tram N Dao, Kyle B Lupo, Paige Veenhuis, Sandro Matosevic

Cancer Immunol Immunother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy.
Xinyu Wu, Sandro Matosevic

Mol Ther Oncolytics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors.
Andrea M Chambers, Kyle B Lupo, Jiao Wang, Jingming Cao, Sagar Utturkar, Sandro Matosevic

Elife· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rora Regulates Neutrophil Migration and Activation in Zebrafish.
Alan Y Hsu, Tianqi Wang, Ramizah Syahirah, Sheng Liu, Kailing Li, Sandro Matosevic

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Lung Cancer: Current Landscape and Future Directions.
Hirva Mamdani, Sandro Matosevic, Ahmed Bilal Khalid, Gregory Durm, Shadia I Jalal

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells.
Jiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia Atallah Lanman, Sandro Matosevic

Proc Natl Acad Sci U S A· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum- and feeder-free conditions.
Kyle B Lupo, Jung-Il Moon, Andrea M Chambers, Sandro Matosevic

Cytotherapy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.
Xue Yao, Sandro Matosevic

BioDrugs· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine networks modulating natural killer cell trafficking to solid tumors.
Xue Yao, Sandro Matosevic

Cytokine Growth Factor Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and metabolic targeting of natural killer cells to solid tumors.
Jiao Wang, Sandro Matosevic

Cell Oncol (Dordr)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation.
Tram N Dao, Sagar Utturkar, Nadia Atallah Lanman, Sandro Matosevic

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
Kyle B Lupo, Sandro Matosevic

J Hematol Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis